bone marrow radiation dosimetry of high dose 131i treatment in differentiated thyroid carcinoma patients

نویسندگان

y. parlak department of nuclear medicine, medical faculty, celal bayar university, bozkoy campus, 45030, manisa, turkey

m. demir department of nuclear medicine, cerrahpasa medical faculty, istanbul university, cerrahpasa, istanbul, turkey

i. cavdar department of nuclear physics, science faculty, istanbul university, istanbul, turkey

s. ereees department of nuclear physics, science faculty, celal bayar university, 45140, manisa, turkey

چکیده

background: radiation absorbed dose to the red bone marrow, a critical organ in the therapy of thyroid carcinoma, is generally kept below 2 gy for non-myeloablative therapies. the aim of this study was to calculate bone marrow radiation dose by using mirdose3 package program and to optimize the safe limit of activity to be administered to the thyroid cancer patients. materials and methods: in this study, 83 thyroid cancer patients were divided into 3 groups based on the amount of activity administered into the body. in the groups, 3700 mbq, 5550 mbq and 7400 mbq activities were used respectively. the curves of time-activity were drawn from blood samples counts and effective half-life and residence time were calculated. correlations of bone marrow radiation dose and radioiodine effective half-life were determined as a function of administered activity via anova test. tg levels and tumour diameters were compared using spearman’s correlation. results: the effective half-lives of 131i for three groups of whole-body, receiving 3700 mbq, 5550 mbq and 7400 mbq were calculated as 20.57±5.4, 17.8±5.8 and 18.7±3.9 hours, respectively. the average bone marrow doses for 3 groups of patients were 0.32±0.08 gy, 0.42±0.14 gy and 0.60±0.24 gy, respectively. conclusion: it was concluded that, the bone marrow dose to the patients still remains within the recommended level even after administering an activity of 7400 mbq of 131i to the patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bone marrow radiation dosimetry of high dose 131I treatment in differentiated thyroid carcinoma patients

Background: Radiation absorbed dose to the red bone marrow, a critical organ in the therapy of thyroid carcinoma, is generally kept below 2 Gy for non-myeloablative therapies. The aim of this study was to calculate bone marrow radiation dose by using MIRDOSE3 package program and to optimize the safe limit of activity to be administered to the thyroid cancer patients. Materials and Methods: In t...

متن کامل

Bone marrow radiation dosimetry of high dose 131I treatment in differentiated thyroid carcinoma patients

Background: Radia on absorbed dose to the red bone marrow, a cri cal organ in the therapy of thyroid carcinoma, is generally kept below 2 Gy for non-myeloabla ve therapies. The aim of this study was to calculate bone marrow radia on dose by using MIRDOSE3 package program and to op mize the safe limit of ac vity to be administered to the thyroid cancer pa ents. Materials and Methods: In this stu...

متن کامل

Practical dosimetry of 131I in patients with thyroid carcinoma.

Radioiodine treatments of patients with well-differentiated thyroid carcinoma have generally been safe and beneficial. Safety can be ensured while efficacy is increased through practical methods of dosimetry that measure body retention of 131I. Prescriptions for therapeutic 131I can be decreased when the retention level is high and increased when the level is low. Assays of serum free T4 will a...

متن کامل

Radiation dose of caregivers could be reduced in thyroid carcinoma patients requiring high dose of radioactive iodine: A case report

Undesired radiation exposure to caregivers is an important problem in radioiodine therapy in thyroid carcinoma patients, especially when patient is non-ambulatory. Special precautions are needed to keep the exposure to caregivers low when higher dose of radioiodine is necessary. Here we present a case-report of a 74-year old male patient with papillary thyroid carcinoma with local invasion and...

متن کامل

Evaluation of Treatment of Differentiated Carcinoma of Thyroid.

The treatment of patient with differentiated carcinoma of thyroid consists of three stages, surgery, I 1.1.i ablation and hormone therapy. To avoid the problems mentioned in the article, initially the patient should have thyroid scan, T.1 , T4, thyroglobulin estimation and a chest x-ray, prior to surgery which should be carried out by a competent surgeon, in order that total thyroidectomy can b...

متن کامل

Determination of radiation dose rates and urinary activity of patients received Sodium Iodide-131 for treatment of differentiated thyroid carcinoma [Persian]

Sodium Iodide-131 is administrated for treatment of hyperthyroidism and thyroid cancer. Iodine-131 has multiple routs of excretion (Urine, saliva, sweat, milk, feces, exhalation) from the body. Patients receiving Sodium Iodide-131 therapy exposes other persons and the environment to unwanted radiation and contamination. The major source of radiation dose from administration of Iodine-131 ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of radiation research

جلد ۱۴، شماره ۲، صفحات ۹۹-۱۰۴

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023